Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001209191-23-016456

Options or other derivatives

  • General Counsel acquired 46,656 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Murdock Hunter R. General Counsel 2023-03-02 Grant or award · Employee Stock Option (Right to Buy) +29,773 29,773 D
Murdock Hunter R. General Counsel 2023-03-02 Grant or award · Restricted Stock Units +16,883 16,883 D
Loading xslF345X03/doc4.xml…